RIGL Financial Facts
Basic (in shares): 71.23MBasic (in dollars per share): -0.25
See Full Income Statement
Other assets: 2.05M
Available-for-sale securities: 247M
See Full Balance Sheet
Rigel Pharmaceuticals, Inc. (RIGL) Earnings
|
Expand Research on RIGL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -8.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/9/22 | Q222 | N/A | -$0.13 | N/A | N/A | $23.13M | N/A | N/A | N/A | ||
| 5/3/22 |  |
Q122 | -$0.16 | -$0.14 | -$0.02 | $16.74M | $17.54M | N/A |  | | Details |
| 3/1/22 | |
Q421 | -$0.13 | -$0.13 | $0.00 | $20.4M | $21.9M | N/A | | | Details |
| 11/2/21 | |
Q321 | -$0.12 | -$0.10 | -$0.02 | $21.5M | $23.56M | N/A | | | Details |
8/3/21  |
|
Q221 | N/A | -$0.11 | N/A | N/A | $20.37M | N/A | N/A | N/A | |
| 5/5/21 |
|
Q121 | N/A | $0.00 | N/A | N/A | $31.05M | N/A | N/A | N/A | |
| 3/2/21 | |
Q420 | -$0.11 | -$0.11 | $0.00 | $18.45M | $18.1M | N/A | | | Details |
| 11/5/20 |
|
Q320 | N/A | -$0.12 | N/A | N/A | $17.24M | N/A | N/A | N/A |
